Skip to main content

Table 3 Evaluation of the effect of HFCWO on two subgroups of patients receiving or not a RM

From: Chest physiotherapy improves lung aeration in hypersecretive critically ill patients: a pilot randomized physiological study

 

Not receiving RM (n = 30)

Receiving RM (n = 30)

 
 

T0

T1

T2

T3

T0

T1

T2

T3

pvalue

Not ventilated area (%)

0.2 [0.0; 2.8]

1.1 [0.0; 3.9]

0.4 [0.0; 4.2]

0.9 [0.0; 4.2]

0.6 [0.0; 2.8]

0.3 [0.0; 2.5]

0.0 [0.0; 3.0]

0.6 [0.0; 3.0]

0.893

TIV (mL)

446 [336; 488]

429 [361; 497]

433 [357; 509]

440 [345; 497]

473 [366; 607]

472 [414; 629]

471 [382; 578]

490 [67; 563]

0.111

 Dorsal

158 [138; 222]

158 [121; 214]

161 [133; 217]

157 [119; 240]

193 [160; 247]

210 [156; 266]

205 [169; 243]

209 [174; 240]

0.122

 Ventral

223 [180; 313]

246 [177; 313]

253 [185; 322]

235 [200; 321]

286 [196; 353]

303 [202; 362]

259 [197; 335]

270 [203; 335]

0.679

ΔTIV (mL)

0 [0; 0]

− 4 [− 41; 42]

− 4 [− 42; 47]

− 9 [− 26; 34]

0 [0; 0]

− 2 [34; 66]

− 3 [− 53; 40]

1 [− 23; 27]

0.995

 Dorsal

0 [0; 0]

6 [− 11; 21]

1 [− 23; 20]

4 [− 28; 20]

0 [0; 0]

− 4 [− 16; 29]

6 [− 20; 23]

4 [− 10; 18]

0.906

 Ventral

0 [0; 0]

1 [− 31; 21]

2 [− 24; 28]

− 6 [− 24; 28]

0 [0; 0]

4 [− 20; 31]

− 3 [− 36; 15]

− 4 [− 21; 9]

0.932

Centre of gravity (%)

53.8 [50.8; 56.0]

53.5 [50.8; 56.9]

53.7 [50.2; 57.5]

54.0 [50.3; 56.8]

53.3 [49.6; 54.9]

53.2 [50.0; 55.4]

52.8 [50.2; 54.8]

52.3 [50.1; 54.5]

0.561

ΔEELI (mL)

0 [0; 0]

29 [−59; 108]

0 [−138; 225]

1 [−170; 162]

0 [0; 0]

2 [−95; 153]

126 [−45; 352]

61 [−102; 169]

0.272

 Dorsal

0 [0; 0]

9 [− 30; 125]

6 [− 77; 188]

7 [− 83; 277]

0 [0; 0]

7 [− 51; 140]

88 [− 12; 189]

48 [− 12; 154]

0.069

 Ventral

0 [0; 0]

− 25 [− 84; 40]

− 22 [− 128; 109]

− 23 [− 122; 59]

0 [0; 0]

21 [− 116; 86]

32 [− 94; 175]

42 [− 104; 131]

0.413

Heart rate (beat/min)

79 (14)

81 (16)

79 (18)

77 (16)

84 (16)

84 (16)

82 (17)

80 (16)

0.983

Mean arterial pressure (mmHg)

84 (13)

84 (12)

83 (12)

83 (11)

90 (13)

90 (15)

87 (13)

85 (13)

0.830

Respiratory rate (breath/min)

18 (5)

18 (5)

17 (5)

17 (5)

19 (5)

19 (5)

19 (5)

19 (4)

0.995

pH

7.42 (0.06)

7.42 (0.06)

7.43 (0.06)

7.43 (0.06)

7.42 (0.06)

7.41 (0.05)

7.42 (0.05)

7.42 (0.05)

0.972

PaCO2 (mmHg)

43.4 (8.5)

43.4 (8.2)

43.7 (8.6)

43.8 (8.3)

41.8 (8.4)

43.1 (9.3)

41.7 (7.8)

41.5 (7.7)

0.926

PaO2/FiO2 (mmHg)

240 (73)

236 (66)

242 (61)

241 (62)

212 (58)

217 (57)

221 (54)

218 (49)

0.977

  1. RM recruiting manoeuvre, T0 baseline assessment, T1 assessment soon after the end of the treatment, T2 assessment 1 h after the end of the treatment, T3 assessment 3 h after the end of the treatment, TIV tidal impedance variation, ΔTIV difference of TIV from T0, ΔEELI difference of end-expiratory lung impedance from T0, PaCO2 arterial partial pressure of carbon dioxide, PaO2/FiO2 ratio between arterial partial pressure and inspired fraction of oxygen